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Abstract
AHRE´ N, BO, LINDA J. MAGRUM, PETER J. HAVEL,
STEPHANIE F. GREENE, STEPHEN D. PHINNEY,
PATRICIA R. JOHNSON, AND JUDITH S. STERN. Aug-
mented insulinotropic action of arachidonic acid through the
lipoxygenase pathway in the obese Zucker rat. Obes Res.
2000;8:475–480.
Objective: The metabolism of arachidonic acid (AA) has
been shown to be altered in severe insulin resistance that is
present in obese (fa/fa) Zucker rats. We examined the ef-
fects and mechanism of action of AA on basal and glucose-
stimulated insulin secretion in pancreatic islets isolated
from obese (fa/fa) Zucker rats and their homozygous lean
(Fa/Fa) littermates.
Research Methods and Procedures: Islets were isolated
from 10- to 12-week-old rats and incubated for 45 minutes
in glucose concentrations ranging from 3.3 to 16.7 mM with
or without inhibitors of the cyclooxygenase or lipoxygenase
pathways. Medium insulin concentrations were measured
by radioimmunoassay, and islet production of the 12-
lipoxygenase metabolite, 12-hydroxyeicosatetraenoic acid
(12-HETE), was measured by enzyme immunoassay.
Results: In islets from lean animals, AA stimulated insulin
secretion at submaximally stimulatory glucose levels
(,11.1 mM) but not at 16.7 mM glucose. In contrast, in
islets derived from obese rats, AA potentiated insulin se-
cretion at all glucose concentrations. AA-induced insulin
secretion was augmented in islets from obese compared
with lean rats at high concentrations of AA in the presence
of 3.3 mM glucose. Furthermore, the inhibitor of 12-lipoxy-
genase, esculetin (0.5 mM), inhibited AA-stimulated insulin
secretion in islets from obese but not lean rats. Finally, the
islet production of the 12-HETE was markedly enhanced in
islets from obese rats, both in response to 16.7 mM glucose
and to AA.
Discussion: The insulin secretory response to AA is aug-
mented in islets from obese Zucker rats by a mechanism
related to enhanced activity of the 12-lipoxygenase pathway.
Therefore, augmented action of AA may be a mechanism
underlying the adaptation of insulin secretion to the increased
demand caused by insulin resistance in these animals.
Key words: Insulin secretion, arachidonic acid, Zucker
rats, lipoxygenase
Introduction
In obesity, insulin sensitivity in peripheral tissues is re-
duced. This reduction is compensated by increased insulin
secretion from pancreatic islets, leading to hyperinsulinemia
(1–3). If the increase in insulin secretion is inadequate in
relation to the demand induced by insulin resistance, glu-
cose intolerance or diabetes evolves (3,4). Although there is
evidence for roles by modest hyperglycemia, increased cho-
linergic activity (5,6), or increased circulating levels of free
fatty acids (7) to contribute to the adaptive increase in
insulin secretion in insulin resistance, the underlying mech-
anisms remain incompletely understood. Therefore, inves-
tigation of the mechanisms that mediate augmented insulin
secretion in insulin resistance is likely to lead to a better
understanding of the pathogenesis of glucose intolerance
and diabetes. One model useful for the investigation of
insulin secretion and action in obesity is the obese (fa/fa)
Zucker rat, which exhibits hyperphaghia and obesity result-
ing from a Gln269 3 Pro mutation in the extracellular
domain of the leptin receptor (8,9). The net result of the
leptin insensitivity is a phenotype characterized by periph-
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eral insulin insensitivity, hyperinsulinemia, and hypersecre-
tion of insulin in response to glucose from enlarged islets
(10–15). It has also been shown that in this model the
hyperinsulinemia may even precede the peripheral insulin
insensitivity (16), making the pathways responsible for in-
sulin secretion in this model of particular interest. Because
the fatty Zucker rats do not exhibit overt hyperglycemia and
diabetes, this model allows the study of islets from obese,
hyperinsulinemic, insulin-resistant animals that have not
been chronically exposed to high glucose levels.
Phinney and colleagues (17,18) have established that a
relationship exists between the metabolism of arachidonic
acid (AA) and obesity in the Zucker rat, including altered
distribution of AA in liver and in muscle, and that these
abnormalities are correlated with the hyperinsulinemia. In
view of these findings, it is possible that altered metabolism
of AA or altered responsiveness to AA might contribute to
some of the metabolic abnormalities observed in obese
Zucker rats. This is of particular relevance for the aug-
mented insulin secretion, because AA is known to function
as a second messenger in the signaling pathways regulating
insulin secretion through the activation of phospholipase A2
and diacylglyceride lipase (19–25). AA may also be of
importance for insulin secretion by serving as the substrate
for several key signaling substances modulating insulin
secretion, including those derived from the cyclooxygenase,
lipoxygenase, and cytochrome P450 pathways (26–28). It is
therefore possible that alterations in AA metabolism con-
tribute to the exaggerated insulin secretion in obesity. In the
present study, we have examined the influence of AA on
glucose-stimulated insulin secretion from isolated islets de-
rived from obese (fa/fa) Zucker rats and their lean litter-
mates (Fa/Fa). We have also examined the influence of the
inhibitor of cyclooxygenase, sodium salicylate, and the in-
hibitor of 12-lipoxygenase, esculetin (23,29), on AA-stim-
ulated insulin secretion as well as the production of the
12-lipoxygenase-derived product, 12-hydroxyeicosatetra-
enoic acid (12-HETE), in the islets.
Research Methods and Procedures
Experimental Animals
Ten- to twelve-week-old male obese (fa/fa) and homozy-
gous lean (Fa/Fa) Zucker rats were obtained from the
Animal Model Core of the Clinical Nutrition Research Unit
at the University of California, Davis. Animals were housed
in stainless steel, wire-bottom, hanging cages and main-
tained on a 12-hour light:dark cycle with ad libitum access
to food (Purina rat chow) and water.
Isolation of Pancreatic Islets
Pancreatic islets were isolated by the collagenase isola-
tion technique according to Lacy and Kostianovsky (30)
with slight modifications. The common bile duct was li-
gated at the distal end, and the pancreas was distended with
8 mL of Hanks’ balanced salt solution (HBSS) (JRH Bio-
sciences). The pancreas was excised, cleaned of fat and
other tissue, and minced. Excess HBSS was removed and 6
mL of solution of collagenase, type IX (0.85 mg/ml of 1650
units/mg; Sigma Chemical, St Louis, MO), in HBSS was
added. Tissue was digested by gentle shaking in a 37 °C
water bath for 9–10 minutes. The digest was rinsed twice
with 45 to 50 mL of medium (RPMI 1640 with the addition
of 3.3 mM glucose and 10% fetal bovine serum; JRH
Biosciences) and resuspended in 30 mL of the same me-
dium. Islets were collected with an Eppendorf pipette under
a dissection microscope. Islets were incubated in the above
medium for 2 hours at 37 °C in an atmosphere of 5% CO2
before use in experiments.
Insulin Secretion Experiments
Incubated islets were rinsed with warm Krebs Ringer
bicarbonate (KRB) supplemented with 3.3 mM glucose, 5
mM HEPES, pH 7.4, and then transferred (10 islets per
well) to 24-well Falcon cell culture plates containing KRB
as above. KRB was removed under magnification and re-
placed with KRB supplemented with glucose, AA (prepared
in a stock solution of 500 mM in KRB with 3.3 mM
glucose), esculetin, and/or sodium salicylate (all from
Sigma) according to the experimental protocols. Islets were
then incubated in a shaking water bath at 37 °C in an
atmosphere of 95% O2 and 5% CO2 for 45 minutes. After
incubation, plates were placed on ice, and 0.5 mL of ice-
cold KRB supplemented with 0.2% fatty acid free bovine
serum albumin (Sigma) was added, resulting in a final
concentration of 0.1% bovine serum albumin. The medium
was then removed under magnification and stored at 220
°C until it was assayed for insulin or 12-HETE.
Assays
Insulin in the medium was analyzed by radioimmuno-
assay using a single antibody method and polyethylene
precipitation as described previously (31) with the use of rat
insulin standard (Novo Biolabs, Wilton, CT), porcine
anti-rat insulin (ICN Diagnostics Division, Costa Mesa,
CA), 125I-labeled rat insulin (Amersham Pharmacia Bio-
tech, Arlington Heights, IL), and polyethylene glycol
(Sigma). 12-HETE was measured by enzyme immunoas-
say using a kit available from Advanced Magnetics, Inc.
(Cambridge, MA).
Statistics
Results are reported as mean 6 SEM. For the statistical
comparison of means between groups, ANOVA with the
Student-Newman-Keul post hoc test and Bonferroni correc-
tion for multiple comparison was applied. A p value of
#0.05 was considered statistically significant.
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Results
Insulin Secretory Response to AA
The relationship between the media concentrations of AA
and insulin secretion at 3.3 mM glucose in islets isolated
from lean and obese rats is shown in Figure 1. The insulin-
otropic action of AA was more pronounced in islets derived
from obese animals than from lean animals, as judged by the
larger increase in insulin secretion at 250 or 500 mM of AA
(p , 0.05). Similarly, when islets derived from lean rats
were incubated in the presence of AA (100 mM) at glucose
concentrations ranging from 3.3 to 16.7 mM, glucose-stim-
ulated insulin secretion was augmented at glucose concen-
trations lower than 16.7 mM, but not at 16.7 mM glucose
(p , 0.05 or less). In contrast, in islets from obese animals,
AA augmented insulin release at all glucose levels (p ,
0.05 or less; Figure 2). Thus, at high glucose and at high
concentrations of AA, islets from obese animals responded
with exaggerated insulin secretion compared with islets
from lean rats. In the presence of 16.7 mM glucose, the
inhibitor of cyclooxygenase, sodium salicylate (100 mM),
stimulated insulin secretion when added together with AA
in islets derived from lean rats (p , 0.05) but had no effect
on AA-stimulated insulin secretion from obese rats. In con-
trast, the inhibitor of 12-lipoxygenase, esculetin (0.5 mM),
inhibited AA-stimulated insulin secretion in islets from
obese (p , 0.01) but not from lean animals (Figure 3).
Together these results suggest that AA-induced insulin se-
cretion from islets obtained from obese animals is less
sensitive to inhibition by cyclooxygenase-derived metabo-
lites but more sensitive to inhibition of 12-lipoxygenase
than islets from lean animals.
Islet 12-HETE Production
At 16.7 mM glucose, 12-HETE production was signifi-
cantly higher in islets isolated from obese rats than from
lean rats (p , 0.01). At 100 mM, AA markedly increased
the release of 12-HETE into the incubation medium con-
taining islets from obese but not from lean rats (Figure 4).
Esculetin (0.5mM) reduced the production of 12-HETE
induced by AA in islets from obese rats (p , 0.05).
Discussion
It has previously been demonstrated that the effect of
exogenous AA on insulin secretion from pancreatic islets
from non-obese animals is highly dependent on the ambient
glucose level, because a stimulation is usually observed at
low glucose levels (32–34), whereas an inhibition or no
effect is observed at high glucose concentrations (33,34).
The stimulatory action of AA on insulin secretion has been
thought to be mediated by AA-induced release of Ca21
from intracellular pools, stimulation of the activity of pro-
tein kinase C, and through indirect actions induced by
lipoxygenase-derived metabolites (22,27,33,35,36). In con-
trast, the inhibitory action of AA on insulin secretion, seen
at high glucose levels, is most likely due to production of
substances that inhibit insulin secretion, such as prostaglan-
dins, which are known to counteract the effect of glucose
(26). The net effect of AA might therefore depend on the
relative formation of cyclooxygenase- and lipoxygenase-
derived metabolites.
In this study we confirm that AA stimulates insulin
secretion at submaximally stimulatory but not at maximal
glucose levels in islets isolated from normal rats. This is
consistent with previously reported studies of islets from
other strains of rats (32–34). The major finding in the
present study is, however, that in contrast to islets from lean
animals, the islets obtained from obese Zucker rats exhib-
ited a stimulatory effect of AA also at high glucose con-
centrations. We also show that the insulinotropic response
to AA at high dose levels in the presence of 3.3 mM glucose
was higher in islets isolated from obese than from lean rats.
Whether this reflects a more marked insulinotropic effi-
ciency of AA also at lower glucose levels or simply the
difference in islet size was not examined. Sodium salicylate
did not affect this augmented insulin response in islets from
obese rats, but the inhibitor or 12-lipoxygenase, esculetin,
did. Although we did not verify that cyclooxygenase activ-
ity was reduced by salicylate in our experiments, our results
suggest that the stimulatory action of AA on insulin secre-
tion from islets from obese rats is dependent on the forma-
tion of 12-lipoxygenase-derived products. Lipoxygenase is
activated by glucose and by AA (37,38), and through its
Figure 1. Insulin secretion from islets derived from lean (Fa/Fa) or
obese (fa/fa) Zucker rats incubated in the presence of 3.3 mM
glucose and varying concentrations of arachidonic acid. Means 6
SEM of four incubations each consisting of 10 islets in each data
point are shown. Asterisks indicate the probability level of random
difference between groups of islets incubated with and without
arachidonic acid (**p , 0.05; ***p , 0.001).
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activation, 12-HETE, its precursor, 12-hydroperoxyeicosa-
tetraneoic acid (12-HPETE), hepoxilins, and trioxilins are
formed (35,37,38). Some of these products have been pre-
viously shown to stimulate insulin secretion (27,35,36).
Therefore, we examined the production of 12-HETE from
islets derived from obese and lean Zucker rats, and we
confirmed that 12-HETE is produced by islets (compare
with Refs. 37 and 38). We also found that the islet formation
of 12-HETE is exaggerated in islets from obese Zucker rats,
that esculetin reduced this production, and that the reduction
of glucose-stimulated 12-HETE production by esculetin
was more pronounced in islets obtained from obese animals
than in islets from lean animals. These results suggest that
the activity of the 12-lipoxygenase pathway is enhanced in
islets from obese rats. Whether this is due to increased
expression of or increased substrate availability for the
12-lipoxygenase enzyme remains to be established.
Our results demonstrate that 1) esculetin inhibits the
production of 12-HETE and concomitantly inhibits AA-
stimulated insulin secretion in islets from obese but not
from lean rats and 2) the islets from obese animals exhibit
exaggerated production of 12-HETE. Taken together, these
results suggest that products of the 12-lipoxygenase path-
way are important in the stimulation of insulin secretion by
AA in obesity. Esculetin more potently suppressed AA-
induced insulin secretion than it reduced 12-HETE forma-
tion. This could be due either to a nonlinear relation be-
tween these two processes or to other mechanisms of
esculetin on insulin secretion that are not related to the
lipoxygenase pathway. In any case, the previous demonstra-
tion that AA metabolism is altered in obese Zucker rats
(5,6), together with the present results, suggests that altered
AA metabolism is a significant contributor to the hyper-
secretion of insulin by the endocrine pancreas of the obese
Zucker rat. Whether AA is an important intracellular mes-
senger for islet adaptation to insulin resistance in other
models of obesity remains to be studied.
Figure 2. Insulin secretion from islets derived from lean (Fa/Fa;
upper panel) or obese (fa/fa; lower panel) Zucker rats incubated in
the presence of 100 mM arachidonic acid and varying concentra-
tions of glucose. Means 6 SEM of six incubations each consisting
of 10 islets in each data point are shown. Asterisks indicate the
probability level of random difference between groups of islets
isolated from lean vs. obese Zucker rats (*p , 0.01; ***p ,
0.001).
Figure 3. Insulin secretion from islets derived from lean (Fa/Fa) or
obese (fa/fa) Zucker rats incubated in the presence of 16.7 mM
glucose, 100 mM arachidonic acid, and sodium salicylate (100
mM) or esculetin (0.5 mM). Means 6 SEM of three incubations
each consisting of 10 islets in each data point are shown. Asterisks
indicate the probability level of random difference between islets
incubated with arachidonic acid with or without an inhibitor (*p ,
0.05; **p , 0.01).
Arachidonic Acid and Insulin Secretion in Zucker Rats, Ahre´n et al.
478 OBESITY RESEARCH Vol. 8 No. 6 Sept. 2000
Acknowledgments
The study was supported by a grant from the Nora Eccles
Treadwell Foundation; NIH Grants DK-18899, DK-35747,
DK-20579, DK-50129, and DK-4073202; Swedish Medical
Research Council Grants 14X-6834 and 12X-712; and by
the Albert Påhlsson Foundation, the Swedish Diabetes As-
sociation, the American Diabetes Association, and the Fac-
ulty of Medicine, Lund University.
References
1. Porte D Jr. b-Cells in type II diabetes mellitus. Diabetes.
1991;40:166–80.
2. DeFronzo RA, Bonnadonna RC, Ferranini E. Pathogenesis
of NIDDM: a balanced overview. Diabetes Care. 1992;15:
318–68.
3. Larsson H, Ahre´n B. Islet dysfunction in obese women with
impaired glucose tolerance. Metabolism. 1996;45:502–9.
4. Larsson H, Ahre´n B. Failure to adequately adapt reduced
insulin sensitivity with increased insulin secretion in
women with impaired glucose tolerance. Diabetologia.
1996;39:1099 –107.
5. Ahre´n B, Simonsson E, Scheurink AJW, Mulder H,
Myrse´n U, Sundler F. Dissociated insulinotropic sensitivity
to glucose and carbachol in high-fat diet-induced insulin re-
sistance in C57BL/6J mice. Metabolism. 1997;46:97–106.
6. Ahre´n B, Sauerberg P, Thomsen C. Increased insulin secre-
tion and normalisation of glucose tolerance by cholinergic
agonism in high-fat fed C57BL/6J mice. Am J Physiol. 1999;
277:E93–E102.
7. McGarry JD, Dobbins RL. Fatty acids, lipotoxicity and
insulin secretion. Diabetologia. 1999;42:128–38.
8. Philips MS, Liu QY, Hammond HA, et al. Leptin receptor
missense mutation in the fatty Zucker rat. Nat Genet. 1996;
13:18–9.
9. Iida M, Murakami T, Ishida K, Mizuno A, Kuwajima M,
Shima K. Substitution at codon 269 (glutamine3proline) of
the leptin receptor (OB-R) cDNA is the only mutation found
in the Zucker fatty (fa/fa) rat. Biochem Biophys Res Commun.
1996;224:597–604.
10. Zucker LM, Antoniades H. Insulin and obesity in the Zucker
genetically obese rat “fatty.” Endocrinology. 1972;90:1320–30.
11. Stern JS, Johnson PR, Batchelor BR, Zucker LM, Hirsch
J. Pancreatic insulin release and peripheral tissue resistance in
Zucker obese rats fed high- and low-carbohydrate diets. Am J
Physiol. 1975;228:543–8.
12. Blonz ER, Stern JS, Curry DL. Dynamics of pancreatic
insulin release in young Zucker rats: a heterozygote effect.
Am J Physiol. 1985;248:E188–E93.
13. Johnson PR, Stern JS, Greenwood MR, Hirsch J. Adipose
tissue hyperplasia and hyperinsulinemia of Zucker obese female
rats: a developmental study. Metabolism. 1978;27:1941–54.
14. Curry DL, Stern JS. Dynamics of insulin hypersecretion by
obese Zucker rats. Metabolism. 1985;34:791–6.
15. Kuffert A, Stern JS, Curry DL. Pancreatic hypersensitivity
to glucose by young obese Zucker rats (fa/fa). Metabolism.
1988;37:952–7.
16. Turkenkopf IJ, Johnson PR, Greenwood MRC. Develop-
ment of pancreatic and plasma insulin in prenatal and suckling
Zucker rats. Am J Physiol. 1982;242:E220–5.
17. Phinney SD, Tang AB, Thurmond DC, Nakamura MT,
Stern JS. Abnormal polyunsaturated lipid metabolism in the
obese Zucker rat, with partial metabolic correction by gamma-
linolenic acid administration. Metabolism. 1992;42:1127–40.
18. Ayre KJ, Phinney SD, Tang AB, Stern JS. Exercise training
reduces skeletal muscle membrane arachidonate in the obese
(fa/fa) Zucker rat. J Appl Physiol. 1998;85:1898–902.
19. Jones PM, Persaud SJ. Arachidonic acid as a second mes-
senger in glucose-induced insulin secretion from pancreatic
beta-cells. J Clin Endocrinol. 1993;137:7–14.
20. Loweth AC, Scarpello JB, Morgan NG. Phospholipase A2
expression in human and rodent insulin-secreting cells. Mol
Cell Endocrinol. 1995;112:177–83.
21. Gross RW, Ramanadham S, Kruszka KK, Han X, Turk J.
Rat and human pancreatic islet cells contain a calcium ion
independent phospholipase A2 activity selective for hydrolysis
of arachidonate which is stimulated by adenosine trisphos-
phate and is specifically localized to islet beta-cells. Biochem-
istry. 1993;32:327–36.
22. Ramandham S, Gross RW, Han X, Turk J. Inhibition of
arachidonate release suppresses both insulin secretion and the
rise in b-cell cytosolic Ca21 concentration. Biochemistry.
1993;32:337–46.
Figure 4. Concentrations of 12-HETE in media from islets derived
from lean (Fa/Fa) or obese (fa/fa) Zucker rats incubated in the
presence of 16.7 mM glucose, 100 mM arachidonic acid, and/or
esculetin (0.5 mM). Means 6 SEM of three incubations each
consisting of five islets in each data point are shown. The asterisk
indicates the probability level of p , 0.05 between islets incubated
with arachidonic acid with or without addition of esculetin.
Arachidonic Acid and Insulin Secretion in Zucker Rats, Ahre´n et al.
OBESITY RESEARCH Vol. 8 No. 6 Sept. 2000 479
23. Simonsson E, Karlsson S, Ahre´n B. Involvement of phos-
pholipase A2 and arachidonic acid in cholecystokinin-8-
induced insulin secretion. Regul Pept. 1996;65:101–7.
24. Simonsson E, Karlsson S, Ahre´n B. Ca21-independent phos-
pholipase A2 contributes to the insulinotropic action of cho-
lecystokinin-8 in rat islets: dissociation from the mechanism
of carbachol. Diabetes. 1998;47:1436–43.
25. Konrad RJ, Major CD, Wolf BA. Diacylglycerol hydrolysis to
arachidonic acid is necessary for insulin secretion from isolated
pancreatic islets: sequential actions of diacylglycerol and mono-
acylglycerol lipases. Biochemistry. 1994;33:13284–94.
26. Robertson RP. Eicosanoids as pluripotential modulators of
pancreatic islet function. Diabetes. 1988;37:367–70.
27. Metz SA. Putative roles for lysophospholipids as mediators
and lipoxygenase-mediated metabolites of arachidonic acid as
potentiators of stimulus-secretion coupling: dual mechanisms
of p-hydroxymercuribenzoic acid-induced insulin release.
J Pharmacol Exp Ther. 1986;238:819–32.
28. Falck JR, Manna S, Moltz J, Chacos N, Capdevila J.
Epoxyeicosatrienoic acids stimulate glucagon and insulin re-
lease from isolated rat pancreatic islets. Biochem Biophys Res
Commun. 1983;114:743–9.
29. Huang HC, Lai MW, Wang HR, Chung YL, Hsieh LM,
Chen CC. Antiproliferative effect of esculetin on vascular
smooth muscle cells: possible roles of signal transduction
pathways. Eur J Pharmacol. 1993;237:39–44.
30. Lacy PE, Kostianovsky M. Method for the isolation of intact
islets of Langerhans from the rat pancreas. Diabetes. 1967;16:
35–9.
31. Desbuquois B, Aurbach GD. Use of polyethylene glycol to
separate free and antibody-bound peptide hormones in radio-
immunoassays. J Clin Endocrinol Metab. 1971;33:732–8.
32. Metz SA. Exogenous arachidonic acid promotes insulin re-
lease from intact or permeabilized rat islets by dual mecha-
nisms: putative activation of Ca21 mobilization and protein
kinase C. Diabetes. 1988;37:1453–69.
33. Band AM, Jones PM, Howell SL. The mechanism of ara-
chidonic acid-induced insulin secretion from rat islets of
Langerhans. J Mol Endocrinol. 1992;8:95–101.
34. Landt M, Easom RA, Colca JR, et al. Parallel effects of
arachidonic acid on insulin secretion, calmodulin-dependent
protein kinase activity and protein kinase C activity in pan-
creatic islets. Cell Calcium. 1992;13:163–72.
35. Pace-Asciak CR, Martin JM, Corey EJ, Su WG. Endoge-
nous release of hepoxilin A3 from isolated perifused pancre-
atic islets of Langerhans. Biochem Biophys Res Commun.
1985;128:942–6.
36. Metz SA, Fujimoto WY, Robertson RP. A role for the
lipoxygenase pathway of arachidonic acid metabolism in glu-
cose- and glucagon-induced insulin secretion. Life Sci. 1983;
32:903–10.
37. Metz SA. Glucose increases the synthesis of lipoxygenase-
mediated metabolites of arachidonic acid in intact rat islets.
Proc Natl Acad Sci USA. 1985;82:198–202.
38. Shannon VR, Ramanadham S, Turk J, Holtzman MJ.
Selective expression of an arachidonate 12-lipoxygenase by
pancreatic islet beta-cells. Am J Physiol. 1992;263:E828–E36.
Arachidonic Acid and Insulin Secretion in Zucker Rats, Ahre´n et al.
480 OBESITY RESEARCH Vol. 8 No. 6 Sept. 2000
